mgr Katarzyna Ciapała
Strona główna
/
Instytut
/
Pracownicy
/
mgr Katarzyna Ciapała
mgr Katarzyna Ciapała
Dokonania naukowe
- Publikacje
New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies
Autorzy: Ciechanowska, A., Rojewska, E., Piotrowska, A., Barut, J., Pawlik, K., Ciapała, K., Kreiner, G., Mika, J.
DOI: 10.3389/fimmu.2022.1058204
Date: 2022-01-01
Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain
Autorzy: Zajaczkowska, R., Rojewska, E., Ciechanowska, A., Pawlik, K., Ciapała, K., Kocot-Kępska, M., Makuch, W., Wordliczek, J., Mika, J.
DOI: 10.3390/ph15010088
Date: 2022-01-01
Promising Anticonvulsant and/or Analgesic Compounds Among 5-Chloro-2- or 5-Chloro-4-Methyl Derivatives of Xanthone Coupled to Aminoalkanol Moieties – Design, Synthesis and Pharmacological Evaluation
Autorzy: Mazur, G., Pańczyk-Straszak, K., Rapacz, A., Kiszela, J., Smolik, M., Gawlik, M., Walczak, M., Czekajewska, J., Karczewska, E., Żesławska, E., Nitek, W., Niedbał, A., Leśniak, J., Ciapala, K., Pawlik, K., Mika, J., Waszkielewicz, A.M.
DOI: 10.2139/ssrn.4066150
Date: 2022-01-01
The kynurenine pathway as a potential target for neuropathic pain therapy design: From basic research to clinical perspectives
Autorzy: Ciapała, K., Mika, J., Rojewska, E.
DOI: 10.3390/ijms222011055
Date: 2021-01-01
Initiators of classical and lectin complement pathways are differently engaged after traumatic brain injury—time-dependent changes in the cortex, striatum, thalamus and hippocampus in a mouse model
Autorzy: Ciechanowska, A., Ciapała, K., Pawlik, K., Oggioni, M., Mercurio, D., De Simoni, M.-G., Mika, J.
DOI: 10.3390/ijms22010045
Date: 2021-01-01
Comparison of the effects of chemokine receptors CXCR2 and CXCR3 pharmacological modulation in neuropathic pain model—In vivo and in vitro study
Autorzy: Piotrowska, A., Ciapała, K., Pawlik, K., Kwiatkowski, K., Rojewska, E., Mika, J.
DOI: 10.3390/ijms222011074
Date: 2021-01-01
Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain
Autorzy: Pawlik, K., Ciechanowska, A., Ciapała, K., Rojewska, E., Makuch, W., Mika, J.
DOI: 10.3389/fimmu.2021.781310
Date: 2021-01-01
CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain
Autorzy:
DOI: 10.3389/fimmu.2020.01241
Date: 2020-07-14
The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain
Autorzy: Katarzyna Pawlik, Anna Piotrowska, Klaudia Kwiatkowski, Katarzyna Ciapała, Katarzyna Popiolek‐Barczyk, Wioletta Makuch, Joanna Mika
DOI: 10.1111/imm.13172
Date: 2020-04-01
Kinurenines in Central Nervous System under neuropathic pain – clinical implications from basic research
Autorzy: Katarzyna Ciapała, Ewelina Rojewska
DOI: 10.5604/01.3001.0013.7396
Date: 2020-01-16